Burley Brewton was able to count on a new advancement in targeted therapy after he was diagnosed with prostate cancer, the ...
Atlanta Falcons Legends join Emory Healthcare to raise awareness for prostate and lung cancer screening. Early detection can ...
The assay detects aggressive prostate tumors in men on active surveillance for low-risk cancer, potentially helping them ...
A groundbreaking trial for a prostate cancer treatment with fewer side effects has launched in the UK. Backed by the ...
The recent FDA approval of the IsoPSA blood test may represent a notable advancement in prostate cancer screening and diagnosis. Developed by Cleveland Diagnostics, the in vitro diagnostic instrument ...
Investigators analyzed exfoliated cells in urine specimens to identify 50 candidate RNAs for prostate cancer detection.
A rare Gleason 10 prostate cancer in an 80‑year‑old veteran with a persistently low PSA… The Most EXTREME Prostate Cancer ...
The FDA has approved a novel diagnostic for prostate cancer that looks to improve upon the common screener for ...
IsoPSA is a blood assay that detects variations of the PSA protein that signal a higher likelihood of high-grade tumors. It ...
The IsoPSA test is intended to help assess whether patients with elevated PSA levels should go on to receive a biopsy ...
This satellite symposium at the European Society for Medical Oncology (ESMO) Congress 2025, chaired by Rana McKay, Professor ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback